フィリピンの医療市場動向

◆英語タイトル:CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
◆商品コード:GDHC0060CHR
◆発行会社(調査会社):GlobalData
◆発行日:2016年8月16日
◆ページ数:199
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:フィリピン
◆販売価格オプション(消費税別)
Single UserUSD1,995 ⇒換算¥227,430見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD3,990 ⇒換算¥454,860見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD5,985 ⇒換算¥682,290見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



【レポートの概要】

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Philippines”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008–2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%. These positive trends can primarily be attributed to:

An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices

Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)

An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Philippines healthcare market

【レポートの目次】

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 GlobalData Report Guidance

3 Executive Summary

4 Overview of Pharmaceutical and Medical Device Market

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Exports and Imports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Overview of Major Disease Areas

4.1.6 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Reimbursement and Payer Landscape

5.1.1 Overview of Healthcare system

5.1.2 Reimbursement Process

5.1.3 Overview of Insurance Providers

5.1.4 Patient Share in Healthcare Spending

5.1.5 Price Trends in the Healthcare Sector

5.1.6 Pricing Policies

5.2 Regulatory Landscape

5.2.1 Overview of Regulatory Agencies

5.2.2 Market Authorization Procedure for Pharmaceutical Products

5.2.3 New Medical Device Approval Process

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5 Exports and Imports

5.2.6 Intellectual Property Rights

5.2.7 Clinical Trial Regulations

5.2.8 Pharmaceutical Advertising Regulations

5.2.9 Pharmacy Regulations

5.2.10 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Analysis of Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.2 Economic Landscape

6.3 Economic Indicators

6.3.1 Gross Domestic Product

6.3.2 Gross National Income

6.3.3 Inflation

6.3.4 Currency Exchange Rate

6.3.5 Foreign Direct Investment

6.3.6 Foreign Exchange Reserves

6.3.7 Trade Balance

6.3.8 Fiscal Deficit

6.3.9 General Government Gross Debt

6.3.10 External Debt

6.3.11 Major Industries

6.4 Demographics

6.4.1 Population

6.4.2 Education and Literacy

6.4.3 Employment

6.4.4 Disease Burden

6.5 Healthcare Infrastructure

6.5.1 Healthcare Facilities

6.5.2 Healthcare Parameters

6.5.3 Environmental Health

6.5.4 Healthcare Personnel

6.6 Healthcare Expenditure

6.6.1 Overview

6.6.2 Major Components of Healthcare Spending

6.6.3 Share of Public and Private Sector

6.6.4 Spending in Pharmaceutical R&D

6.7 Trade Associations

6.7.1 Pharmaceutical and Healthcare Association of the Philippines

6.7.2 The Philippine Pharmaceutical Manufacturers Association

6.7.3 The Philippine Pharmacist Association

6.7.4 The Philippine Medical Association

6.8 Trade Fairs

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

List Of Tables

Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016–2020

Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008–2014

Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008

Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016

Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015

Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016

Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014–2018

Table 11: Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck, 2016

Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016

Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016

Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008–2015

Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008–2014

Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008–2015

Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016–2020

Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008–2015

Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016–2020

Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008–2014

Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008–2013

Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008–2013

Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008–2015

Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008–2014

Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008–2014

Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008–2015

Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008–2015

Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008–2014

Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008–2015

Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008–2015

Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012–2013

Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013–2014

Table 34: Demographics, Philippines, Population (million), 2008–2015

Table 35: Demographics, Philippines, Population (million), 2016–2020

Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008–2015

Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016–2020

Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008–2015

Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020

Table 40: Demographics, Philippines, Births (per 1,000 Population), 2008–2014

Table 41: Demographics, Philippines, Mortality (per 1,000 Population), 2008–2014

Table 42: Demographics, Philippines, Major Causes of Mortality (‘000), 2013

Table 43: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 2008–2015

Table 44: Demographics, Philippines, Immunization Rate (%), 2008–2014

Table 45: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013

Table 46: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013

Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 2008–2014

Table 48: Demographics, Philippines, Gender Ratio (M:F), 2008–2014

Table 49: Demographics, Philippines, Life Expectancy at Birth (Years), 2008–2015

Table 50: Demographics, Philippines, Life Expectancy at Birth (Years), 2016–2020

Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008–2014

Table 52: Demographics, Philippines, Unemployment Rate (%), 2008–2015

Table 53: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013

Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009

Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008–2014

Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008–2014

Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009

Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 2007–2009

Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 2008–2014

Table 60: Environmental Health, Philippines, CO2 Emissions (Million Tons), 2008–2014

Table 61: Environmental Health, Philippines, PM2.5(µg/m³), 2008–2014

Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008–2014

Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008–2014

Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008–2014

Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013

Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008–2014

Table 67: Major Healthcare Trade Fairs, Philippines, 2016

List Of Figures

Figure 1: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2008–2020

Figure 2: Country Profile, Philippines, 2016

Figure 3: Pharmaceutical Market, Philippines, Revenue ($bn), 2008–2015

Figure 4: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016–2020

Figure 5: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008–2014

Figure 6: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008

Figure 7: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008

Figure 8: Healthcare Market, Philippines, Drivers and Barriers, 2016

Figure 9: Healthcare System, Philippines, 2016

Figure 10: Drug Selection Procedure for Philippine National Drug Formulary, Philippines, 2016

Figure 11: Reimbursement Process, Philippines, 2016

Figure 12: PhilHealth Milestones, Philippines, 2016

Figure 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016

Figure 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016

Figure 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008–2015

Figure 16: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008–2014

Figure 17: Food and Drug Administration Structure, Philippines, 2014

Figure 18: Approval Process of New Drugs and Medical Devices, Philippines, 2014

Figure 19: Approval Process of Generic Drugs, Philippines, 2016

Figure 20: Bureau of Health Devices and Technology Structure, Philippines, 2016

Figure 21: Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, Philippines, 2016

Figure 22: Patent Approval Process, Philippines, 2016

Figure 23: Trademark Approval Process, Philippines, 2016

Figure 24: Clinical Trial Approval Process, Philippines, 2014

Figure 25: Procedure for Opening a Retail Pharmacy, Philippines, 2014

Figure 26: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999–2014

Figure 27: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008–2015

Figure 28: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016–2020

Figure 29: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008–2015

Figure 30: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016–2020

Figure 31: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008–2014

Figure 32: Economic Indicators, Philippines, Average Consumer Price Index, 2008–2013

Figure 33: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008–2013

Figure 34: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008–2015

Figure 35: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008–2014

Figure 36: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008–2014

Figure 37: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008–2015

Figure 38: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008–2015

Figure 39: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008–2014

Figure 40: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008–2015

Figure 41: Economic Indicators, Philippines, External Debt ($bn), 2008–2015

Figure 42: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013–2014

Figure 43: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013–2014

Figure 44: Demographics, Philippines, Population (million), 2008–2015

Figure 45: Demographics, Philippines, Population (million), 2016–2020

Figure 46: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008–2015

Figure 47: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016–2020

Figure 48: Demographics, Philippines, Population Distribution by Age Group (%), 2008–2015

Figure 49: Demographics, Philippines, Population Distribution by Age Group (%), 2016–2020

Figure 50: Demographics, Philippines, Births (per 1,000 Population), 2008–2014

Figure 51: Demographics, Philippines, Mortality (per 1,000 Population), 2008–2014

Figure 52: Demographics, Philippines, Major Causes of Mortality (‘000), 2013

Figure 53: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 2008–2015

Figure 54: Demographics, Philippines, Immunization Rate (%), 2008–2014

Figure 55: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013

Figure 56: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013

Figure 57: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 2008–2014

Figure 58: Demographics, Philippines, Gender Ratio (M:F), 2008–2014

Figure 59: Demographics, Philippines, Life Expectancy at Birth (Years), 2008–2015

Figure 60: Demographics, Philippines, Life Expectancy at Birth (Years), 2016–2020

Figure 61: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008–2014

Figure 62: Demographics, Philippines, Unemployment Rate (%), 2008–2015

Figure 63: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013

Figure 64: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009

Figure 65: Healthcare Infrastructure, Philippines, Hospitals, 2008–2014

Figure 66: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008–2014

Figure 67: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009

Figure 68: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 2007–2009

Figure 69: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 2008–2014

Figure 70: Environmental Health, Philippines, CO2 Emissions (Million Tons), 2008–2014

Figure 71: Environmental Health, Philippines, PM2.5 (µg/m³), 2008–2014

Figure 72: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008–2014

Figure 73: Healthcare Personnel, Philippines, Registered Nurses, 2008–2014

Figure 74: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008–2014

Figure 75: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013

Figure 76: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008–2014

Figure 77: Healthcare Market, Philippines, Opportunities and Challenges, 2016



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[フィリピンの医療市場動向]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月06日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆